Trial · NCT06126991
Organ Protective Effect of Cetirizine In Patients With Severe Burns
NCT06126991, Phase 1, Phase 2, Unknown, Ruijin Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Organ Protective Effect of Cetirizine In Patients With Severe Burns. Trials, record NCT06126991. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06126991
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Organ Protective Effect of Cetirizine In Patients With Severe Burns
- NCT number
- NCT06126991
- Status
- Unknown
- Phases
- Phase 1, Phase 2
- Enrollment
- 32 participants, estimated
- Lead sponsor
- Ruijin Hospital
- Conditions
- Burns
- Interventions
- Cetirizine, Midazolam and Fentanyl
- First posted
- 2023-11-13
- Last updated
- 2024-02-01
Source ClinicalTrials.gov
Registered outcomes21
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | APACHE II on Day 7 | Day 7 | Observation of APACHE II scores of patients in each group 7 days after admission. The APACHE II (Acute Physiology And Chronic Health Evaluation II) is a severity-of-disease classification system. An integer score from 0 to 71 is computed based on several measurements. Higher scores correspond to more severe disease and a higher risk of death. |
| Secondary | Urinary Output | Day 7 | Observation of 24-hour urinary output (ml) 7 days after admission. |
| Secondary | Blood L-lactate | Day 7 | Observation of Blood L-lactate level 7 days after admission. |
| Secondary | Base Excess (BE) | Day 7 | Observation of base excess in blood 7 days after admission. |
| Secondary | Oxygen Saturation | Day 7 | Observation of oxygen saturation in blood 7 days after admission. |
| Secondary | Stroke Volume Variation | Day 7 | Observation of stroke volume variation (SVV) in PICCO or Uscom 7 days after admission. |
| Secondary | Global End-Diastolic Volume | Day 7 | Observation of global end-diastolic volume (GEDV) in PICCO or Uscom 7 days after admission. |
| Secondary | Central Venous Pressure | Day 7 | Observation of central venous pressure (CVP) in PICCO or Uscom 7 days after admission. |
| Secondary | Stroke Volume | Day 7 | Observation of stroke volume 7 days after admission. |
| Secondary | Cardiac Function Index | Day 7 | Observation of Cardiac Function Index (CFI) 7 days after admission. |
1 to 10 of 21Source ClinicalTrials.gov
See all 21 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06126991
GET https://conductscience.org/api/trials/v1/NCT06126991/registered?page=2